Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26052,819,0.72 [0.61-0.86],0.00033358208123
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27171,351,0.60 [0.46-0.77],5.698563292909582e-05
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27171,351,0.60 [0.46-0.77],5.698563292909582e-05
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24842,702,0.46 [0.38-0.55],6.15303884323125e-17
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26992,446,0.52 [0.41-0.65],8.530809774624204e-09
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26479,116,0.30 [0.21-0.42],1.115652731050777e-12
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26465,102,0.30 [0.21-0.42],8.912528909502587e-12
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26694,331,0.22 [0.17-0.29],3.7239738043471524e-30
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26685,322,0.22 [0.17-0.28],3.5582692142290784e-30
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24678,538,0.39 [0.32-0.48],1.300095828457322e-19
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24213,73,0.40 [0.25-0.63],8.010681597096133e-05
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24633,493,0.39 [0.31-0.48],6.946994696697236e-19
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter VI Diseases of the nervous system,Hemiplegia,28066,53,0.37 [0.25-0.54],5.756315908167793e-07
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27694,134,0.46 [0.32-0.68],7.116150229213239e-05
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28065,24,0.31 [0.18-0.54],2.206414032882817e-05
PLA2G7,Platelet-activating factor acetylhydrolase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",26305,24,0.31 [0.18-0.52],1.0900906642265598e-05
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22154,1970,0.51 [0.45-0.58],8.706410827546787e-26
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23226,1308,0.46 [0.40-0.53],1.1652302009528834e-24
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Hypertension,23249,1331,0.46 [0.39-0.53],2.02606734591056e-25
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21967,49,0.34 [0.21-0.53],4.07469076200468e-06
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26788,572,0.36 [0.30-0.44],2.7165713157509277e-24
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Angina pectoris,26568,352,0.38 [0.30-0.48],6.020078902739428e-16
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27597,139,0.38 [0.27-0.54],3.955646570875925e-08
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27722,264,0.32 [0.25-0.42],1.3094013676197273e-17
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28212,61,0.28 [0.17-0.46],7.21644452592144e-07
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26379,163,0.29 [0.21-0.39],4.1228817308215664e-15
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26628,423,0.31 [0.25-0.39],5.661462444088393e-25
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21975,57,0.39 [0.23-0.64],0.0002189970282472
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27779,113,0.34 [0.25-0.48],4.5312113172857587e-10
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27812,84,0.31 [0.21-0.44],1.4585989469288583e-10
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27860,73,0.28 [0.19-0.40],1.9703532066580976e-11
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27610,83,0.43 [0.27-0.67],0.0001841901075755
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25917,883,0.74 [0.62-0.88],0.0008175738146861
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",26529,800,0.69 [0.58-0.83],6.265527858782152e-05
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter X Diseases of the respiratory system,Asthma,21677,800,0.70 [0.58-0.84],0.0001733646333648
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21530,800,0.70 [0.58-0.84],0.000174874898655
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21661,784,0.70 [0.58-0.85],0.000237450895839
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22708,130,2.80 [1.69-4.62],6.030204183262819e-05
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XI Diseases of the digestive system,Hernia,25513,1188,1.40 [1.19-1.65],6.352443136351053e-05
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XI Diseases of the digestive system,Inguinal hernia,24729,404,2.37 [1.78-3.17],4.291702648119852e-09
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27975,74,0.42 [0.27-0.67],0.0002566885342027
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",28232,105,0.46 [0.30-0.70],0.0002990559246398
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XI Diseases of the digestive system,Crohn disease,26765,105,0.46 [0.30-0.70],0.0002523154384759
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26740,80,0.44 [0.28-0.69],0.0003103746109455
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26791,42,0.34 [0.18-0.65],0.0009752041677862
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21922,3546,0.82 [0.74-0.90],7.08682576973014e-05
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25852,1117,0.77 [0.65-0.90],0.0009043253755912
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23931,4434,0.54 [0.49-0.59],5.5972024954070295e-43
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11493,413,0.63 [0.48-0.82],0.0006116603522589
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27931,241,1.99 [1.39-2.85],0.0001849687280827
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27859,169,2.95 [1.91-4.56],1.092509229858177e-06
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26775,893,0.66 [0.56-0.78],1.735130247424547e-06
PLA2G7,Platelet-activating factor acetylhydrolase,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26511,629,0.64 [0.52-0.78],1.0290423475363455e-05
